Former VP at Teladoc Health Inc
- US telehealth market overview, highlighting Teladoc Health's (NYSE: TDOC) competitive positioning
- Expansion strategy and scaling efforts, including ability to lower SG&A costs
- Growth channels for legacy business including attractive ancillary add-ons
- Go-to-market strategy, focusing on customer acquisition and business model adaptation
- 2022-23 outlook – key success drivers and business risks, including integration timeline for Livongo acquisition
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.